Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research

Journal of Controlled Release

Volumn 172, Issue 3, 2013, Pages 1075-1091

  Elzoghby, Ahmed O ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Drug delivery; Gelatin nanocomplexes; Gelatin nanoparticles; Gene delivery; Pharmaceutical applications; Surface modifications

Indexed keywords

GELATIN NANOPARTICLES; GENE DELIVERY; NANOCOMPLEXES; PHARMACEUTICAL APPLICATIONS; SURFACE-MODIFICATIONS;

BIOCOMPATIBILITY; BIODEGRADATION; BIOPOLYMERS; DRUG DELIVERY; EMULSIFICATION; GENE TRANSFER; MICROEMULSIONS; PHASE SEPARATION;

NANOPARTICLES;

ALKALINE PHOSPHATASE; ANGIOGENIC BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 2; CAMPTOTHECIN; CISPLATIN; CURCUMIN; CYANAMIDE; CYCLOHEXIMIDE; CYTARABINE; DOXORUBICIN; EPIGALLOCATECHIN GALLATE; FIBROBLAST GROWTH FACTOR; GELATIN; GELATIN NANOPARTICLE; HYDROCORTISONE; INSULIN; METHOTREXATE; MICROSPHERE; N HYDROXYSUCCINIMIDE; NANOPARTICLE; NOSCAPINE; NUTRACEUTICAL; PACLITAXEL; PILOCARPINE; POLYPHENOL; RESVERATROL; TANESPIMYCIN; TETANUS TOXOID; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIODEGRADATION; CELL TRANSPORT; CHEMICAL STRUCTURE; COACERVATION; COACERVATION PHASE SEPARATION; CROSS LINKING; CYTOTOXICITY; DESOLVATION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; DRUG UPTAKE; EMULSION; ENZYME IMMOBILIZATION; EVAPORATION; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; HUMAN; IN VITRO STUDY; INTRAOCULAR DRUG ADMINISTRATION; MICELLE; MICROEMULSION; MOLECULAR WEIGHT; NANOENCAPSULATION; NANOPRECIPITATION; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHASE SEPARATION; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE PHASE MICROEMULSION; REVIEW; SOLVATION; STATIC ELECTRICITY; SURFACE CHARGE; ZETA POTENTIAL;

DRUG DELIVERY; GELATIN NANOCOMPLEXES; GELATIN NANOPARTICLES; GENE DELIVERY; PHARMACEUTICAL APPLICATIONS; SURFACE-MODIFICATIONS;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELATIN; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 84887288919     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.09.019     Document Type: Review

References (151)

1. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B: Biointerfaces 75 2010 1 18
2. A.O. Elzoghby, W.M. Samy, and N.A. Elgindy Protein-based nanocarriers as promising drug and gene delivery systems J. Control. Release 161 2012 38 49
3. S. Kommareddy, D.B. Shenoy, and M.M. Amiji Gelatin nanoparticles and their biofunctionalization C.S.S.R. Kumar, Nanotechnologies for the Life Sciences, Vol. 1 Biofunctionalization of Nanomaterials 2005 WILEY-VCH Verlag GmbH & Co. KGaA Weinheim 330 352
4. H. Wang, O.C. Boerman, K. Sariibrahimoglu, Y. Li, J.A. Jansen, and S.C.G. Leeuwenburgh Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: bone morphogenetic protein-2 and alkaline phosphatase Biomaterials 33 2012 8695 8703
5. S. Busch, U. Schwarz, and R. Kniep Chemical and structural investigations of biomimetically grown fluorapatite-gelatin composite aggregates Adv. Funct. Mater. 13 2003 189 198
6. B. Mohanty, V.K. Aswal, J. Kohlbrecher, and H.B. Bohidar Synthesis of gelatin nanoparticles via simple coacervation J. Surf. Sci. Technol. 21 2005 149 160 (Pubitemid 43864506)
7. J.J. Marty, R.C. Oppenheim, and P. Speiser Nanoparticles - a new colloidal drug delivery system Pharm. Acta Helv. 53 1978 17 23
8. C.A. Farrugia, and M.J. Groves Gelatin behaviour in dilute aqueous solution: designing a nanoparticulate formulation J. Pharm. Pharmacol. 51 1999 643 649 (Pubitemid 29346704)
9. C. Coester, K. Langer, H. Von Briesen, and J. Kreuter Gelatin nanoparticles by two-step desolvation - a new preparation method, surface modification and cell uptake J. Microencapsul. 17 2000 187 193 (Pubitemid 30135796)
10. K. Ofokansi, G. Winter, G. Fricker, and C. Coester Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery Eur. J. Pharm. Biopharm. 76 2010 1 9
11. Z. Lu, T.K. Yeh, M. Tsai, J.L.S. Au, and M.G. Wientjes Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy Clin. Cancer Res. 10 2004 7677 7684 (Pubitemid 39557532)
12. M.G. Cascone, L. Lazzeri, and Z. Zho Gelatin nanoparticles prepared by a simple W/O emulsion as delivery system for methotrexate J. Mater. Sci. Mater. Med. 13 2002 523 526 (Pubitemid 34454486)
13. A.K. Bajpai, and J. Choubey Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate J. Mater. Sci. Mater. Med. 17 2006 345 358
14. A.K. Bajpai, and J. Choubey In vitro release dynamics of an anticancer drug from swellable gelatin nanoparticles J. Appl. Polym. Sci. 101 2006 2320 2332 (Pubitemid 44117487)
15. J. Choubey, and A.K. Bajpai Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin J. Mater. Sci. Mater. Med. 21 2010 1573 1586
16. Y.-Z. Zhao, X. Li, C.-T. Lu, Y.-Y. Xu, H.-F. Lv, D.-D. Dai, L. Zhang, C.-Z. Sun, W. Yang, X.-K. Li, Y.-P. Zhao, H.-X. Fu, L. Cai, M. Lin, L.-J. Chen, and M. Zhang Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy Acta Diabetol. 49 2012 315 325
17. A.K. Gupta, M. Gupta, S.J. Yarwood, and A.S.G. Curtis Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organization of human fibroblasts J. Control. Release 95 2004 197 207 (Pubitemid 38230035)
18. M.J. Hou, M. Kim, and D.O. Shah A light scattering study on the droplet size and interdroplet interaction in microemulsion of AOT-oil water systems J. Colloid Interface Sci. 123 1998 398 412
19. D.Q. Guerrero, E. Allemann, H. Fessi, and E. Doelker Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers Drug Dev. Ind. Pharm. 24 1998 1113 1128 (Pubitemid 28546092)
20. E.J. Lee, S.A. Khan, J.K. Park, and K.-H. Lim Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation Bioprocess Biosyst. Eng. 35 2012 297 307
21. U. Bilati, E. Allemann, and E. Doelker Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles Eur. J. Pharm. Sci. 24 2005 67 75 (Pubitemid 40051288)
22. S.A. Khan, and M. Schneider Improvement of nanoprecipitation technique for preparation of gelatin nanoparticles and potential macromolecular drug loading Macromol. Biosci. 13 2013 455 463
23. S.Y. Fung, H. Yang, and P. Chen Formation of colloidal suspension of hydrophobic compounds with an amphiphilic self-assembling peptide Colloids Surf. B: Biointerfaces 55 2007 200 211 (Pubitemid 46274248)
24. K.J. Kim, and Y. Byun Preparation and characterizations of self-assembled PEGylated gelatin nanoparticles Biotechnol. Bioprocess Eng. 4 1999 210 214
25. W.-M. Li, D.-M. Liu, and S.-Y. Chen Amphiphilically-modified gelatin nanoparticles: self-assembly behavior, controlled biodegradability, and rapid cellular uptake for intracellular drug delivery J. Mater. Chem. 21 2011 12381 12388
26. Y.-W. Won, S.-M. Yoon, C.H. Sonn, K.-M. Lee, and Y.-H. Kim Nano self-assembly of recombinant human gelatin conjugated with α-tocopheryl succinate for Hsp90 inhibitor, 17-AAG, delivery ACS Nano 5 2011 3839 3848
27. T. Tanigo, R. Takaoka, and Y. Tabata Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration J. Control. Release 143 2010 201 206
28. S. Han, M. Li, X. Liu, H. Gao, and Y. Wu Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery Colloids Surf. B: Biointerfaces 102 2013 833 841
29. Y.-C. Chen, S.-H. Yu, G.-J. Tsai, D.-W. Tang, F.-L. Mi, and Y.-P. Peng Novel technology for the preparation of self-assembled catechin/gelatin nanoparticles and their characterization J. Agric. Food Chem. 58 2010 6728 6734
30. Z. Li, and L. Gu Effects of mass ratio, pH, temperature, and reaction time on fabrication of partially purified pomegranate ellagitannin-gelatin nanoparticles J. Agric. Food Chem. 59 2011 4225 4231
31. H. Ai, S.A. Jones, and Y.M. Lvov Biomedical application of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles Cell Biochem. Biophys. 39 2003 23 43 (Pubitemid 41282439)
32. T.G. Shutava, S.S. Balkundi, P. Vangala, J.J. Steffan, R.L. Bigelow, J.A. Cardelli, D.P. O'Neal, and Y.M. Lvov Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols ACS Nano 3 2009 1877 1885
33. S. Kommareddy, and M.M. Amiji Preparation and loading of gelatin nanoparticles Cold Spring Harb. Protoc. 2008 10.1101/pdb.prot4887 (Pubitemid 351802467)
34. E. Leo, M.A. Vandelli, R. Cameroni, and F. Forni Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the crosslinking process Int. J. Pharm. 155 1997 75 82 (Pubitemid 27368124)
35. M.J.A. Van Luyn, P.B. Van Wachem, P.J. Dijkstra, L.H.H. Olde Damink, and J. Feijen Calcification of subcutaneously implanted collagens in relation to cytotoxicity, cellular interactions and crosslinking J. Mater. Sci. Mater. Med. 6 1995 288 296
36. B. Ballantyne, and S.L. Jordan Toxicological, medical, and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures J. Appl. Toxicol. 21 2001 131 151 (Pubitemid 32288362)
37. M.A. Vandelli, F. Rivasi, P. Guerra, F. Forni, and R. Arletti Gelatin microspheres crosslinked with d,l-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies Int. J. Pharm. 215 2001 175 184 (Pubitemid 32206615)
38. A.O. Elzoghby, W.M. Samy, and N.A. Elgindy Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride Pharm. Res. 30 2013 512 522
39. A.O. Elzoghby, M.W. Helmy, W.M. Samy, and N.A. Elgindy Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: formulation, characterization and in vivo pharmacokinetics Eur. J. Pharm. Biopharm. 84 2013 487 496
40. F. Song, L.-M. Zhang, C. Yang, and L. Yan Genipin-crosslinked casein hydrogels for controlled drug delivery Int. J. Pharm. 373 2009 41 47
41. Y.-W. Won, and Y.-H. Kim Recombinant human gelatin nanoparticles as a protein drug carrier J. Control. Release 127 2008 154 161
42. H. Zhou, X. Sun, L. Zhang, P. Zhang, J. Li, and Y.-N. Liu Fabrication of biopolymeric complex coacervation core micelles for efficient tea polyphenol delivery via a green process Langmuir 28 2012 14553 14561
43. N.T. Qazvini, and S. Zinatloo Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic crosslinking system J. Mater. Sci. Mater. Med. 22 2011 63 69
44. R. Lantto Protein crosslinking with oxidative enzymes and transglutaminase. Effects in meat protein systems VTT Publ. 642 2007 1 114 (Pubitemid 47569681)
45. T. Heidebach, P. Foerst, and U. Kulozik Transglutaminase-induced caseinate gelation for the microencapsulation of probiotic cells Int. Dairy J. 19 2008 77 84
46. S. Fuchs, M. Kutscher, T. Hertel, G. Winter, M. Pietzsch, and C. Coester Transglutaminase: new insights into gelatin nanoparticle crosslinking J. Microencapsul. 27 2010 747 754
47. A.N. Jǎtariu, M.N. Holban, C.A. Peptu, A. Sava, M. Costuleanu, and M. Popa Double crosslinked interpenetrated network in nanoparticle form for drug targeting - preparation, characterization and biodistribution studies Int. J. Pharm. 436 2012 66 74
48. D. Narayanan, M.G. Geena, H. Lakshmi, M. Koyakutty, S. Nair, and D. Menon Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug ibuprofen-sodium: an in vitro and in vivo analysis Nanomedicine 9 2013 818 828
49. M. Nahar, D. Mishra, V. Dubey, and N.K. Jain Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles Nanomedicine 4 2008 252 261
50. B. Zhao, J. Xie, and J. Zhao A novel water-soluble nanoparticles of hypocrellin B and their interaction with a model protein: C-phycocyanin Biochim. Biophys. Acta 1670 2004 113 120 (Pubitemid 38120318)
51. J. Vandervoort, and A. Ludwig Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use Eur. J. Pharm. Biopharm. 57 2004 251 261 (Pubitemid 38283701)
52. V.L. Truong-Le, J.T. August, and K.W. Leong Controlled gene delivery by DNA-gelatin nanospheres Hum. Gene Ther. 9 1998 1709 1717 (Pubitemid 28418741)
53. A. Saxena, K. Sachin, H.B. Bohidar, and A.K. Verma Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nanoparticles Colloids Surf. B: Biointerfaces 45 2005 42 48 (Pubitemid 41207658)
54. G. Kaul, and M. Amiji Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery Pharm. Res. 19 2002 1062 1068
55. E. Leo, R. Cameroni, and F. Forni Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates Int. J. Pharm. 180 1999 23 30 (Pubitemid 29131439)
56. Y.-W. Won, and Y.-H. Kim Preparation and cytotoxicity comparison of type A gelatin nanoparticles with recombinant human gelatin nanoparticles Macromol. Res. 17 2009 464 468
57. S. Azarmi, Y. Huang, H. Chen, S. McQuarrie, D. Abrams, W. Roa, W.H. Finlay, G.G. Miller, and R. Löbenberg Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells J. Pharm. Pharm. Sci. 9 2006 124 132
58. M. Brzoska, K. Langer, C. Coester, S. Loitsch, T.O.F. Wagner, and C.v. Mallinckrodt Incorporation of biodegradable nanoparticles into human airway epithelium cells - in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases Biochem. Biophys. Res. Commun. 318 2004 562 570 (Pubitemid 38553816)
59. C. Coester, P. Nayyar, and J. Samuel In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localization Eur. J. Pharm. Biopharm. 62 2006 306 314 (Pubitemid 43356580)
60. S. Karthikeyan, N.R. Prasad, A. Ganamani, and E. Balamurugan Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells Biomed. Prev. Nutr. 3 2013 64 73
61. N. Kuntworbe, and R. Al-Kassas Design and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatin nanoparticles as a novel approach for the treatment of malaria AAPS PharmSciTech 13 2012 568 581
62. J.C. Zillies, K. Zwiorek, F. Hoffmann, A. Vollmar, T.J. Anchordoquy, G. Winter, and C. Coester Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles Eur. J. Pharm. Biopharm. 70 2008 514 521
63. E. Leo, R. Arletti, F. Forni, and R. Cameroni General and cardiac toxicity of doxorubicin-loaded gelatin nanoparticles Farmaco 52 1997 385 388 (Pubitemid 27479491)
64. G.Y. Lee, K. Park, J.H. Nam, S.Y. Kim, and Y. Byun Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice J. Drug Target. 14 2006 707 716 (Pubitemid 44921529)
65. P. Dwivedi, S. Kansal, M. Sharma, R. Shukla, A. Verma, P. Shukla, P. Tripathi, P. Gupta, D. Saini, K. Khandelwal, R. Verma, A.K. Dwivedi, and P.R. Mishra Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo J. Drug Target. 20 2012 883 896
66. M. Garg, J. Madan, R.S. Pandey, S. Sardana, A. Katyal, and R. Chandra Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells Anticancer Drugs 23 2012 836 845
67. B. Gaihre, M.S. Khil, D.R. Lee, and H.Y. Kim Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study Int. J. Pharm. 365 2009 180 189
68. W.-M. Li, S.-Y. Chen, and D.-M. Liu In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging Acta Biomater. 9 2013 5360 5368
69. T.K. Yeh, Z. Lu, M.G. Wientjes, and J.L.-S. Au Formulating paclitaxel in nanoparticles alters its disposition Pharm. Res. 22 2005 867 874 (Pubitemid 40898096)
70. C.-L. Tseng, W.-Y. Su, K.-C. Yen, K.-C. Yang, and F.-H. Lin The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation Biomaterials 30 2009 3476 3485
71. A. Jain, A. Gulbake, A. Jain, S. Shilpi, P. Hurkat, A. Jain, and S.K. Jain Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting J. Microencapsul. 29 2012 95 102
72. D. Ding, Z. Zhu, Q. Liu, J. Wang, Y. Hua, X. Jiang, and B. Liu Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors Eur. J. Pharm. Biopharm. 79 2011 142 149
73. D. Ding, J. Wang, Z. Zhu, R. Li, W. Wu, B. Liu, and X. Jiang Tumor accumulation, penetration, and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticles ACS Appl. Mater. Interfaces 4 2012 1838 1846
74. D. Ding, Z.S. Zhu, R.T. Li, X.L. Li, W. Wu, X.Q. Jiang, and B.R. Liu Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system ACS Nano 5 2011 2520 2534
75. H. YIlmaz, and S.H. SanlIer Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent Artif. Cells Nanomed. Biotechnol. 41 2013 69 77
76. J. Madan, N. Dhiman, S. Sardana, R. Aneja, R. Chandra, and A. Katyal Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses Anticancer Drugs 22 2011 543 555
77. J.K. Li, N. Wang, and X.S. Wu A novel biodegradable system based on gelatin nanoparticles and poly(lactic-coglycolic acid) microspheres for protein and peptide drug delivery J. Pharm. Sci. 86 1997 891 895 (Pubitemid 27344045)
78. J.K. Li, N. Wang, and X.S. Wu Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method J. Microencapsul. 15 1998 163 172 (Pubitemid 28105132)
79. Y. Uesugi, H. Kawata, J.-i. Jo, Y. Saito, and Y. Tabata An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy J. Control. Release 147 2010 269 277
80. Y. Uesugi, H. Kawata, Y. Saito, and Y. Tabata Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator J. Drug Target. 20 2012 224 234
81. H. Wang, Q. Zou, O.C. Boerman, A.W.G. Nijhuis, J.A. Jansen, Y. Li, and S.C.G. Leeuwenburgh Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo J. Control. Release 166 2013 172 181
82. M.S. Sudheesh, S.P. Vyas, and D.V. Kohli Nanoparticle-based immunopotentiation via tetanus toxoid loaded gelatin and aminated gelatin nanoparticles Drug Deliv. 18 2011 320 330
83. G. Kaul, and M. Amiji Protein nanoparticles for gene delivery M. Amiji, Polymeric Gene Delivery: Principles and Applications 2005 CRC Press LLC Boca Raton, FL 429 447
84. P. Magadala, and M. Amiji Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells AAPS J. 10 2008 565 576
85. K. Zwiorek, C. Bourquin, J. Battiany, G. Winter, S. Endres, G. Hartmann, and C. Coester Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides Pharm. Res. 25 2008 551 562 (Pubitemid 351357729)
86. C. Coester, J. Kreuter, H. von Briesen, and K. Langer Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid Int. J. Pharm. 196 2000 147 149 (Pubitemid 30105731)
87. G. Kaul, C. Lee-Parsons, and M. Amiji Poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery Pharm. Eng. 23 2003 1 5
88. G. Kaul, and M. Amiji Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles J. Pharm. Sci. 94 2005 184 198 (Pubitemid 40116382)
89. K.W. Leong, H.Q. Mao, V.L. Truong-Le, K. Roy, S.M. Walsh, and J.T. August DNA-polycation nanospheres as non-viral gene delivery vehicles J. Control. Release 53 1998 183 193 (Pubitemid 28218701)
90. J. Xu, S. Ganesh, and M. Amiji Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery Int. J. Pharm. 427 2012 21 34
91. S. Shah Hypoxia in Tumor Angiogenesis and Metastasis: Evaluation of VEGF and MMP Over-Expression and Down-Regulation of HIF-1α with RNAi in Hypoxic Tumor Cells 2010 (Master's Thesis)
92. M.D. Bhavsar, S.B. Tiwari, and M.M. Amiji Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design J. Control. Release 110 2006 422 430 (Pubitemid 41827496)
93. M.D. Bhavsar, and M.M. Amiji Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS) J. Control. Release 119 2007 339 348 (Pubitemid 46770879)
94. M.D. Bhavsar, and M.M. Amiji Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract AAPS PharmSciTech 9 2008 288 294
95. C. Kriegel, H. Attarwala, and M. Amiji Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract Adv. Drug Deliv. Rev. 65 2013 891 901
96. M.D. Bhavsar, and M.M. Amiji Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease Gene Ther. 15 2008 1200 1209
97. C. Kriegel, and M. Amiji Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease J. Control. Release 150 2011 77 86
98. W. Friess Collagen-material for drug delivery Eur. J. Pharm. Biopharm. 45 1998 113 136
99. G.K. Zorzi, J.E. Párraga, B. Seijo, and A. Sánchez Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy Macromol. Biosci. 11 2011 905 913
100. G.K. Zorzi, L. Contreras-Ruiz, J.E. Párraga, A. López-García, R.R. Bello, Y. Diebold, B. Seijo, and A. Sánchez Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles Mol. Pharm. 8 2011 1783 1788
101. J.O.-H. Sham, Y. Zhang, W.H. Finlay, W.H. Roa, and R. Löbenberg Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung Int. J. Pharm. 269 2004 457 467 (Pubitemid 38045308)
102. S. Fuchs, J. Klier, A. May, G. Winter, C. Coester, and H. Gehlen Towards an inhalative in vivo application of immunomodulating gelatin nanoparticles in horse-related preformulation studies J. Microencapsul. 29 2012 615 625
103. J. Klier, S. Fuchs, A. May, U. Schillinger, C. Plank, G. Winter, H. Gehlen, and C. Coester A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses Pharm. Res. 29 2012 1650 1657
104. T. Zou, S.S. Percival, Q. Cheng, Z. Li, C.A. Rowe, and L. Gu Preparation, characterization, and induction of cell apoptosis of cocoa procyanidins- gelatin-chitosan nanoparticles Eur. J. Pharm. Biopharm. 82 2012 36 42
105. Z. Gan, T. Zhang, Y. Liu, and D. Wu Temperature-triggered enzyme immobilization and release based on cross-linked gelatin nanoparticles PLoS One 7 2012 e47154
106. S.K. Jain, Y. Gupta, A. Jain, A.R. Saxena, P. Khare, and A. Jain Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery Nanomedicine 4 2008 41 48 (Pubitemid 351324205)
107. N. Kuntworbe, M. Ofori, P. Addo, M. Tingle, and R. Al-Kassas Pharmacokinetics and in vivo chemosuppressive activity studies on cryptolepine hydrochloride and cryptolepine hydrochloride-loaded gelatin nanoformulation designed for parenteral administration for the treatment of malaria Acta Trop. 127 2013 165 173
108. M. Nahar, V. Dubey, D. Mishra, P.K. Mishra, A. Dube, and N.K. Jain In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis J. Drug Target. 18 2010 93 105
109. S. Jain, P.U. Valvi, N.K. Swarnakar, and K. Thanki Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B Mol. Pharm. 9 2012 2542 2553
110. G.K. Saraogi, P. Gupta, U.D. Gupta, N.K. Jain, and G.P. Agrawal Gelatin nanocarriers as potential vectors for effective management of tuberculosis Int. J. Pharm. 385 2010 143 149
111. G.K. Saraogi, B. Sharma, B. Joshi, P. Gupta, U.D. Gupta, N.K. Jain, and G.P. Agrawal Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis J. Drug Target. 19 2011 219 227
112. D. Jain, and R. Banerjee Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery J. Biomed. Mater. Res. B Appl. Biomater. 86 2008 105 112 (Pubitemid 351874373)
113. A.A. Haroun, N.R. El-Halawany, C. Loira-Pastoriza, and P. Maincent Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles Drug Dev. Ind. Pharm. 2013 10.3109/03639045.2012.746359
114. R. Kumar, R.C. Nagarwal, M. Dhanawat, and J.K. Pandit In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles J. Biomed. Nanotechnol. 7 2011 325 333
115. V. Singh, and A.K. Chaudhary Development and characterization of rosiglitazone loaded gelatin nanoparticles using two step desolvation method Int. J. Pharm. Sci. Rev. Res. 5 2010 100 103
116. S. Kommareddy, and M. Amiji Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione Bioconjug. Chem. 16 2005 1423 1432 (Pubitemid 41681508)
117. S. Kommareddy, and M. Amiji Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery Nanomedicine 3 2007 32 42 (Pubitemid 46428185)
118. H. Otsuka, Y. Nagasaki, and K. Kataoka PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 2003 403 419 (Pubitemid 36293792)
119. J. Crawford Clinical uses of pegylated pharmaceuticals in oncology Cancer Treat. Rev. 28 2002 7 11 (Pubitemid 34679212)
120. G. Kaul, and M. Amiji Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model J. Drug Target. 12 2004 585 591 (Pubitemid 40100706)
121. G. Kaul, and M. Amiji Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies Pharm. Res. 22 2005 951 961 (Pubitemid 40898105)
122. T. Kushibiki, H. Matsuoka, and Y. Tabata Synthesis and physical characterization of poly(ethylene glycol)-gelatin conjugates Biomacromolecules 5 2004 202 208 (Pubitemid 38181331)
123. S. Kommareddy, and M. Amiji Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice J. Pharm. Sci. 96 2007 397 407 (Pubitemid 46363569)
124. A. Babu, J. Periasamy, A. Gunasekaran, G. Kumaresan, S. Naicker, P. Gunasekaran, and R. Murugesan Polyethylene glycol-modified gelatin/polylactic acid nanoparticles for enhanced photodynamic efficacy of a hypocrellin derivative in vitro J. Biomed. Nanotechnol. 9 2013 177 192
125. K. Zwiorek, J. Kloeckner, E. Wagner, and C. Coester Gelatin nanoparticles as a new and simple gene delivery system J. Pharm. Pharm. Sci. 7 2005 22 28
126. X. Xu, R.M. Capito, and M. Spector Delivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticles J. Biomed. Mater. Res. 84A 2008 73 83 (Pubitemid 350244248)
127. H. Ishikawa, Y. Nakamura, J.-i. Jo, and Y. Tabata Gelatin nanospheres incorporating siRNA for controlled intracellular release Biomaterials 33 2012 9097 9104
128. W.-T. Kuo, H.-Y. Huang, M.-J. Chou, M.-C. Wu, and Y.-Y. Huang Surface modification of gelatin nanoparticles with polyethylenimine as gene vector J. Nanomater. 2011 2011 1 5
129. H. Mimi, K.M. Ho, Y.S. Siu, A. Wu, and P. Li Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells J. Control. Release 158 2012 123 130
130. L. Rabinovick-Guilatt, P. Couvreur, G. Lambert, and C. Dubernet Cationic vectors in ocular drug delivery J. Drug Target. 12 2004 623 633 (Pubitemid 40100710)
131. J.A. Weigel, and P.H. Weigel Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE) J. Biol. Chem. 278 2003 42802 42811 (Pubitemid 37345890)
132. S. Balthasar, K. Michaelis, N. Dinauer, H. von Briesen, J. Kreuter, and K. Langer Preparation and characterization of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes Biomaterials 26 2005 2723 2732 (Pubitemid 39600725)
133. N. Dinauer, S. Balthasar, C. Weber, J. Kreuter, K. Langer, and H. von Briesen Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes Biomaterials 26 2005 5898 5906 (Pubitemid 40803459)
134. Z. Li, R. Zhao, X. Wu, Y. Sun, M. Yao, J. Li, Y. Xu, and J. Gu Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics FASEB J. 19 2005 1978 1985 (Pubitemid 41759743)
135. J. Xu, and M. Amiji Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor targeted gelatin nanoparticles J. Vis. Exp. 59 2012 e3612
136. J. Xu, F. Gattacceca, and M. Amiji Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice Mol. Pharm. 10 2013 2031 2044
137. C.-L. Tseng, S.Y.-H. Wu, W.-H. Wang, C.-L. Peng, F.-H. Lin, C.-C. Lin, T.-H. Young, and M.-J. Shieh Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer Biomaterials 29 2008 3014 3022
138. G. Drin, S. Cottin, E. Blanc, A.R. Rees, and J. Temsamani Studies on the internalization mechanism of cationic cell-penetrating peptides J. Biol. Chem. 278 2003 31192 31201 (Pubitemid 36994635)
139. B. Wei, Y. Wei, K. Zhang, J. Wang, R. Xu, S. Zhan, G. Lin, W. Wang, M. Liu, L. Wang, R. Zhang, and J. Li Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide Biomed. Pharmacother. 63 2009 313 318
140. X.-h. Tian, F. Wei, T.-x. Wang, D. Wang, J. Wang, X.-n. Lin, P. Wang, and L. Ren Blood-brain barrier transport of Tat peptide and polyethylene glycol decorated gelatin-siloxane nanoparticle Mater. Lett. 68 2012 94 96
141. X.-h. Tian, F. Wei, T.-x. Wang, P. Wang, X.-n. Lin, J. Wang, D. Wang, and L. Ren In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain Int. J. Nanomedicine 7 2012 1031 1041
142. X.-H. Tian, Z.-G. Wang, H. Meng, Y.-H. Wang, W. Feng, F. Wei, Z.-C. Huang, X.-N. Lin, and L. Ren Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm Int. J. Nanomedicine 8 2013 865 876
143. N. Nimje, A. Agarwal, G.K. Saraogi, N. Lariya, G. Rai, H. Agrawal, and G.P. Agrawal Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting J. Drug Target. 17 2009 777 787
144. B. Lepenies, J. Yin, and P.H. Seeberger Applications of synthetic carbohydrates to chemical biology Curr. Opin. Chem. Biol. 14 2010 404 411
145. R.T. Lee, M.H. Wang, W.J. Lin, and Y.C. Lee New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes Bioorg. Med. Chem. 19 2011 2494 2500
146. S. Elbert, and J.A. Hubbell Development of fibrin derivatives for controlled release of heparin-binding growth factors J. Control. Release 65 2000 389 402 (Pubitemid 30122941)
147. D. Sarkar Fabrication of an optimized fluorescer encapsulated polymer coated gelatin nanoparticle and study of its retarded release properties J. Photochem. Photobiol. A 252 2013 194 202
148. H. Wang, M.B. Hansen, D.W.P.M. Löwik, J.C.M. van Hest, Y. Li, J.A. Jansen, and S.C.G. Leeuwenburgh Oppositely charged gelatin nanospheres as building blocks for injectable and biodegradable gels Adv. Mater. 23 2011 H119 H124
149. Y. Wang, Y. Zhang, W. Du, C. Wu, and J. Zhao Intelligent core-shell nanoparticles and hollow spheres based on gelatin and PAA via template polymerization J. Colloid Interface Sci. 334 2009 153 160
150. C. Wong, T. Stylianopoulos, J. Cui, J. Martin, V.P. Chauhan, W. Jiang, Z. Popović, R.K. Jain, M.G. Bawendi, and D. Fukumura Multistage nanoparticle delivery system for deep penetration into tumor tissue Proc. Natl. Acad. Sci. U. S. A. 108 2011 2426 2431
151. E.I. Deryugina, M.A. Bourdon, R.A. Reisfeld, and A. Strongin Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2 Cancer Res. 58 1998 3743 3750 (Pubitemid 28376578)